Comparison of Non-Invasive Methods of Assessing Fluid Responsiveness in ED and ICU Patients



Status:Recruiting
Conditions:Hospital
Therapuetic Areas:Other
Healthy:No
Age Range:18 - 90
Updated:4/21/2016
Start Date:November 2014
End Date:December 2016
Contact:Alan Chiem, MD MPH
Email:atchiem@gmail.com
Phone:818-364-3107

Use our guide to learn which trials are right for you!

Accurate assessment of fluid responsiveness (FRes) is central to guiding fluid management in
septic and critically ill patients. As evidence accumulates that both inadequate and
excessive fluid resuscitation are associated with increased morbidity and mortality, it is
simultaneously becoming increasingly clear that current widely used methods to predict FRes
are of questionable accuracy. The optimal technique to predict FRes would be a non-invasive
point-of-care test with not only a high degree of accuracy, but also one which requires
minimal training to perform correctly and may be easily performed repeatedly for serial
evaluation of FRes during the ongoing management of the critically ill patient.

To date, three major ultrasonographic modalities have emerged as viable candidates for the
bedside assessment of FRes: 1) measurement of dynamic changes in inferior vena caval
diameter (IVC-CI), 2) measurement of dynamic changes in peripheral arterial waveform derived
variables (PA Doppler), and 3) echocardiographic measurement of dynamic changes in left
ventricular outflow tract waveform derived variables (LVOT Doppler). In this study, the
investigators will perform the first direct comparison of techniques representing all three
of the above modalities in the prediction of FRes against a non-invasive bioreactance
cardiac output monitor (the Cheetah NICOM™), which has been extensively validated against
gold-standard invasive methods of cardiac output measurement. The investigators will compare
the accuracy of these modalities in both spontaneously breathing and mechanically ventilated
patients using passive leg raise testing (PLR) as a surrogate for volume challenge. In
addition, the investigators will also elicit information from the treating physician(s) on
their clinical assessment of FRes.

The investigators will recruit adult patients in the ED and ICU with sepsis, who have
received an initial bolus of 20-30 cc/kg of IV fluid, and can tolerate the PLR and US
procedures. Prior to US and NICOM measurement, investigators will ask the attending
physician managing the patient regarding their assessment of the their fluid status. Then,
separate investigators will perform US and NICOM measurements independently to ensure
blinding. NICOM data, which has been well validated in septic patients, will be shared with
the attending physician. They will then be asked if this new data will change management.

This is a diagnostic accuracy study comparing selected ultrasound techniques to a well
validated standard for predicting fluid responsiveness in septic patients (NICOM). The
primary outcomes will be reported in sensitivity, specificity, positive predictive value,
negative predictive value, likelihood ratios, and receiver operating characteristic curves.

The timeframe for measurement is within 72 hours of the subjects' admission. Determination
of the outcome (i.e., whether a subject is fluid responsive) is based upon the data
generated by the NICOM device. The NICOM generates data within 5 minutes of assessment. The
ultrasound modalities to be studied will generate data within 5 minutes of assessment as
well. The US data will be compared to the NICOM data to generate the statistics listed in
this protocol. There is no further planned follow-up for the subjects.

1. The investigators will compare the ability of dynamic changes in inferior vena caval
diameter (IVC-CI), dynamic changes in peripheral arterial waveform derived variables
(PA Doppler), and dynamic changes in left ventricular outflow tract waveform derived
variables (LVOT Doppler) to detect fluid responsiveness (FRes) relative to FRes as
assessed by bioreactance cardiac output monitoring before and after passive leg raise
(PLR).

Hypothesis: PA Doppler and LVOT Doppler will have superior sensitivity and specificity
to predict FRes in comparison to IVC-CI.

2. The investigators will evaluate data acquisition duration and data acquisition failure
rate of IVC-CI, PA Doppler, and LVOT Doppler. Hypothesis: PA Doppler will have shorter
data acquisition durations in comparison to LVOT velocity variation and IVC-CI.

Hypothesis: PA Doppler will have lower data acquisition failure rates in comparison to
LVOT velocity variation and IVC-CI.

3. The investigators will compare the ability of IVC-CI, PA Doppler, and LVOT Doppler to
predict FRes in comparison to FRes as predicted by clinical judgment.

Hypothesis: PA Doppler and LVOT Doppler will have superior sensitivity and specificity
to predict FRes in comparison to clinical judgment.

4. The investigators will evaluate the ability of dynamic changes in PA corrected flow
times (cFT) to detect FRes relative to FRes as assessed by bioreactance cardiac output
monitoring before and after PLR. Hypothesis: cFT will have greatest sensitivity and
specificity to predict FRes at a Δflow time threshold of ≥15% after PLR.

Hypothesis: At a Δflow time threshold of ≥15%, cFT will have superior sensitivity and
specificity to detect FRes in comparison to IVC-CI.

Inclusion Criteria:

- Subjects presenting to the ED will be screened in accordance with the Olive View
Medical Center Sepsis Waiver, and subjects meeting two of the following four criteria
will be eligible for inclusion in the study: Temperature >38/100.4 or <36/96.8, heart
rate >90, respiratory rate >20 or PaCO2<32, and WBC >12K or <4K or > 10% bands
(neutrophils). The clinical team will be contacted regarding patients identified
based on this initial screening, and if the patient is determined to have a suspected
infection and a fluid bolus is planned, the patient will be enrolled in the study if
they meet the following criteria:

- Adult between the age of 18 to 90 years old;

- Not pregnant;

- Not using non-invasive positive pressure ventilation (CPAP or BiPAP);

- No history of heart, lung, and/or liver transplant;

- Not determined by the clinical team to be acutely unstable requiring immediate
intervention at the time of data collection, and;

- No contraindications to a passive leg raise test (known or suspected cranio-cerebral
or C-spine injury, venous thrombosis, orthopedic injury requiring immobilization or
traction, or other contraindications as per clinical team).

Exclusion Criteria:

- Pregnant;

- Using non-invasive positive pressure ventilation (CPAP or BiPAP);

- Presence of or suspected elevated intracranial pressure;

- Presence of central venous catheters or other medical devices that prevent the use of
bedside ultrasound;

- History of heart, lung, and/or liver transplant;

- History of critical aortic stenosis or severe aortic insufficiency;

- Determined by the clinical team to be acutely unstable and requiring immediate
intervention at the time of study enrollment or data collection or;

- Has a contraindication to passive leg raise maneuver, e.g. known cervical spinal
injury, deep venous thrombosis, orthopedic injury requiring immobilization or
traction.
We found this trial at
1
site
Sylmar, California 91342
Phone: 818-364-3107
?
mi
from
Sylmar, CA
Click here to add this to my saved trials